MedPath

Corin's Icona Femoral Stem Receives FDA Clearance for Direct Anterior Total Hip Arthroplasty

  • Corin has obtained FDA 510(k) clearance for its Icona femoral stem, designed for direct anterior total hip arthroplasty, facilitating use in ambulatory surgery centers.
  • The Icona femoral stem is a collared, metaphyseal-filling, triple-taper design, developed using data from the CorinRegistry for enhanced performance.
  • Icona's design caters specifically to the direct anterior approach, featuring streamlined instrumentation to optimize efficiency in ambulatory surgery centers.
  • Currently, the Icona femoral stem is accessible through a controlled, limited market release within the United States, allowing for careful monitoring and evaluation.
Corin has announced that it has received FDA 510(k) clearance for its Icona femoral stem, a device intended for use in direct anterior total hip arthroplasty (THA). The design of the Icona stem incorporates considerations for use in ambulatory surgery centers (ASCs).
The Icona femoral stem is distinguished by its collared, metaphyseal-filling, triple-taper design. According to Corin, the stem was developed using data from the CorinRegistry. This design is intended to optimize the biomechanical performance and stability of the implant in THA procedures.
Cynthia Ansari, chief commercial officer at Corin USA, stated that Icona reflects the implementation of real-world data in innovation, with design features tailored to the direct anterior approach and streamlined instrumentation for ASCs. The direct anterior approach is a surgical technique that may offer benefits such as reduced muscle damage and faster recovery times compared to traditional approaches.
The Icona femoral stem is currently available through a limited market release in the United States. This controlled release allows for careful monitoring of the device's performance and patient outcomes in a real-world clinical setting.
Subscribe Icon

Stay Updated with Our Daily Newsletter

Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.

Related Topics

Acuitive Technologies' Citrepore Receives FDA Clearance for Bone Void Filling

Acuitive Technologies has received FDA 510(k) clearance for Citrepore, a synthetic bioactive bone void filler designed for orthopedic applications.

Acuitive Technologies' CITREPORE Receives FDA Clearance as Novel Bone Void Filler

Acuitive Technologies secured FDA 510(k) clearance for CITREPORE, a synthetic bioactive bone void filler utilizing CITREGEN® technology, designed for orthopedic procedures.

Corin Receives FDA Clearance for Icona Femoral Stem in Total Hip Arthroplasty

Corin gains FDA 510(k) clearance for the Icona™ femoral stem, designed using data from the CorinRegistry™ for total hip arthroplasty (THA).

Exactech Receives FDA Clearance for Truliant Porous 3D Tibial Knee Implant

Exactech's Truliant porous 3D tibial tray received FDA 510(k) clearance, marking a significant advancement in cementless knee replacement solutions.

Exactech's Truliant Porous 3D Tibial Implant Receives FDA Clearance for Knee Replacement

Exactech has secured FDA 510(k) clearance for its Truliant® Porous 3D Tibial Tray, an innovative 3D-printed tibial knee implant designed for cementless fixation.

Catalyst OrthoScience's Shoulder Fracture System Receives FDA Clearance

Catalyst OrthoScience has received FDA 510(k) clearance for its innovative shoulder fracture system, expanding its comprehensive orthopedic portfolio.

Catalyst OrthoScience's Shoulder Fracture System Receives FDA Clearance

Catalyst OrthoScience received FDA 510(k) clearance for its Catalyst Fracture Shoulder System, designed for reverse shoulder arthroplasty in proximal humeral fractures.

Corin's Unity Knee Medial Constrained Tibial Insert Receives FDA Clearance for TKA

Corin has received FDA 510(k) clearance for its Unity Knee medial constrained tibial insert, designed for both standard and robotic-assisted total knee arthroplasty (TKA).

Avicenna.AI's CINA-CSpine AI Tool Receives FDA 510(k) Clearance for Cervical Spine Fracture Detection

Avicenna.AI has received FDA 510(k) clearance for its CINA-CSpine tool, designed to detect and assess cervical spine fractures using AI.

THINK Surgical's TMINI Robot Cleared for Zimmer Biomet's Persona Knee System

THINK Surgical received FDA 510(k) clearance for its TMINI robotic system to be used with Zimmer Biomet's Persona Knee System, expanding surgical options.

Reference News

[1]
Corin receives FDA 510(k) clearance of Icona femoral stem - Healio
healio.com · Nov 16, 2024

Corin received FDA 510(k) clearance for its Icona femoral stem, designed for direct anterior total hip arthroplasty, fea...

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy